Medizol

Latanoprost, the active ingredient in Medizol, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It treats open-angle glaucoma and ocular hypertension in adults.

GNH USA supplies Medizol as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is a prostaglandin analog used to lower intraocular pressure in glaucoma and ocular hypertension.

- Open-angle glaucoma: reduces intraocular pressure and slows disease progression. - Ocular hypertension: lowers pressure to prevent development of glaucoma. - Normal-tension glaucoma: helps control intraocular pressure when it is within normal range.

Latanoprost may cause ocular and systemic reactions.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Eye irritation: foreign body sensation or mild burning. - Darkening of iris: gradual increase in pigmentation. - Blurred vision: transient visual disturbance. - Dry eye sensation: mild dryness or discomfort.

Serious or Rare Side Effects: - Increased intraocular pressure: paradoxical pressure rise. - Uveitis: inflammation of the uveal tract. - Corneal edema: swelling of the cornea. - Severe allergic reaction: swelling, itching, or rash. - Vision loss: sudden decrease in visual acuity. - Persistent eye pain: ongoing discomfort requiring medical attention.

Before using Medizol, consider the following precautions.

- Monitor intraocular pressure: regular eye examinations are essential. - Assess for ocular infections: avoid use if active infection is present. - Use with caution in patients with a history of uveitis: may exacerbate inflammation. - Avoid in patients with known hypersensitivity to prostaglandin analogs. - Pregnancy and breastfeeding: use only if the potential benefit justifies the potential risk. - Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost can interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concurrent use with other prostaglandin analog eye drops: may cause excessive pressure reduction. - Combination with ocular anesthetic drops: increased risk of ocular irritation. - Use with systemic carbonic anhydrase inhibitors: may lead to unpredictable intraocular pressure changes.

Moderate Interactions (Monitor Closely): - Co‑administration with beta‑blocker eye drops: additive pressure‑lowering effect. - Use with ocular corticosteroids: may diminish the efficacy of latanoprost. - Concurrent systemic NSAIDs: monitor for altered ocular response.